Bear Market Winners: 3 Healthcare Stocks That Have Soared More Than 30% This Year
Trying to find winners in a bear market is no easy task. Even some of the best blue-chip investments are struggling this year. The S&P 500 has crumbled 20% thus far, and it could get worse before it gets better.
One place where investors can find some winners is in the healthcare industry. Vertex Pharmaceuticals (NASDAQ: VRTX), Veru (NASDAQ: VERU), and TransMedics Group (NASDAQ: TMDX) have been some of the hottest buys this year, and here's a look at why.
Vertex Pharmaceuticals is up 34% this year, and it has been a top stock for good reason; it has plenty of growth potential, and it's generating fantastic results right now. It's a dominant force in the cystic fibrosis business, with top-selling drug Trikafta generating billions in revenue today. And the company doesn't expect its patents on it to expire until 2037. This year, Vertex expects revenue to reach between $8.4 billion and $8.6 billion, for year-over-year growth of approximately 12%.
Source Fool.com
